首页> 外文期刊>American Journal of Translational Research >An experimental research into the potential therapeutic effects of Anti-Osteoporosis Decoction and Yougui Pill on ovariectomy-induced osteoporosis
【24h】

An experimental research into the potential therapeutic effects of Anti-Osteoporosis Decoction and Yougui Pill on ovariectomy-induced osteoporosis

机译:抗骨质疏松症汤和Yougui丸对卵巢切除术造成骨质疏松症的潜在治疗疗效的实验研究

获取原文
       

摘要

Many traditional Chinese medicine tonifying prescriptions for kidney and spleen have been proved to play various roles in osteoporosis. This study aimed to explore whether Anti-Osteoporosis Decoction (AOD) and Yougui Pill (YGP) have potential therapeutic effects on osteoporosis in ovariectomy-induced rat model. The osteoporosis rat model was established with female Wistar rats by the way of ovariectomy. The chosen rats were randomly divided into five groups (control group, model group, sham group, model + AOD group, and model + YGP group). H&E staining was used to detect the bone histological pathology changes. The bone mineral density (BMD) was assessed with dual-energy X-ray absorptiometry. In addition, western blotting assay was applied to explore the expressions of BMP2, Runx2, Collagen I and Opn. Next, we examined the expression of collagen I by immunohistochemistry staining. Finally, the levels of Alkaline phosphatase (ALP), procollagen type I N propeptide (PINP) and β-C-terminal telopeptide of type I collagen (β-CTX) were detected. The results revealed that the OVX osteoporosis model was successfully established. AOD and YGP treatment effectively inhibited osteoporosis and reduced the broken trabecular bones. BMD was increased in AOD and YGP treatment. In addition, AOD and YGP treatment groups significantly increased the ALP levels. Furthermore, AOD and YGP significantly increased the expressions of BMP2, Runx2, Collagen I and Opn, while reduced the levels of PINP and β-CTX in serum compared to OVX model group. In conclusion, AOD and YGP exert regulatory effects on osteoporosis in ovariectomized rats. They may be potential candidates for the therapy and cure of human osteoporosis.
机译:已经证明,许多中医调整肾脏和脾脏处方的患者在骨质疏松症中发挥各种作用。本研究旨在探讨抗骨质疏松症汤(AOD)和YOOD)和YGP)对卵巢切除术诱导的大鼠模型的骨质疏松症具有潜在的治疗作用。通过卵巢切除术方式与女性Wistar大鼠建立骨质疏松大鼠模型。将所选择的大鼠随机分为五组(对照组,模型组,假组,模型+ AOD组和型号+ YGP组)。 H&E染色用于检测骨组织学病理学变化。用双能X射线吸收测定法评估骨矿物密度(BMD)。此外,应用蛋白质印迹测定探索BMP2,RUNX2,胶原I和OPN的表达。接下来,我们检查了免疫组织化学染色的胶原蛋白的表达。最后,检测碱性磷酸酶(ALP),胰岛型In肽(PINP)和I型胶原蛋白(β-CTX)的β-C末端肽的水平。结果表明,OVX骨质疏松症模型成功建立。 AOD和YGP治疗有效地抑制了骨质疏松症并减少了破碎的小梁骨骼。 BMD在AOD和YGP治疗中增加。此外,AOD和YGP治疗组显着增加了ALP水平。此外,AOD和YGP显着增加了BMP2,RUNX2,胶原I和OPN的表达,同时与OVX模型组相比降低了血清中峰值和β-CTX的水平。结论,AOD和YGP对卵巢切除大鼠骨质疏松症的调节作用。它们可能是人类骨质疏松症治疗和治愈的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号